Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics
| ISSN | 03445704, 14320843 |
|---|---|
| Country | Germany |
| Publisher | Springer Verlag |
| Subject Areas | Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics |
| Publication Type | Journals |
| Active Years | 1978-ongoing |
| Competitiveness | 1. (0-20) Least Competitive |
| Publication Time | 2. Quick (1-3 months) |
| Website | Visit journal |
| JIF 2022–2023 | 2.700 |
| 2019-2020 SCR Rank | 3329 |
| 2020-2021 SCR Rank | 4161 |
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 2.896 | 3.093 | 3.143 |
| 2021 | 3.250 | 3.446 | 3.484 |
| 2020 | 2.875 | 3.054 | 3.173 |
| 2019 | 3.012 | 3.133 | 2.975 |
| 2018 | 3.114 | 3.060 | 2.985 |
| 2017 | 2.937 | 3.057 | 3.104 |
| 2016 | 2.958 | 3.171 | 3.068 |
| 2015 | 3.247 | 3.208 | 3.142 |
| 2014 | 3.339 | — | — |
| 2013 | 3.037 | — | — |
| 2012 | 3.183 | — | — |
| 2011 | 3.040 | — | — |
| 2010 | 3.007 | — | — |
| 2009 | 2.859 | — | — |
| 2008 | 2.877 | — | — |
| 2007 | 2.798 | — | — |
| 2006 | 2.854 | — | — |
| 2005 | 2.428 | — | — |
| 2004 | 2.399 | — | — |
| 2003 | 2.288 | — | — |
| 2002 | 2.350 | — | — |
| 2001 | 2.222 | — | — |
| 2000 | 1.989 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.869 |
| 2022 | 0.811 |
| 2021 | 0.848 |
| 2020 | 1.112 |
| 2019 | 1.239 |
| 2018 | 1.199 |
| 2017 | 1.147 |
| 2016 | 1.204 |
| 2015 | 1.266 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 122.000 |
| 2022 | 118.000 |
| 2021 | 114.000 |
| 2020 | 111.000 |
https://www.editorialmanager.com/ccap/default.aspx